These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8976686)

  • 41. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bilirubin influence on oxidative lung damage and surfactant surface tension properties.
    Dani C; Martelli E; Tronchin M; Buonocore G; Longini M; Di Filippo A; Giossi M; Rubaltelli FF
    Pediatr Pulmonol; 2004 Sep; 38(3):179-85. PubMed ID: 15274094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined effects of polymers and KL(4) peptide on surface activity of pulmonary surfactant lipids.
    Lu KW; Taeusch HW
    Biochim Biophys Acta; 2010 Jun; 1798(6):1129-34. PubMed ID: 20188696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phospholipase A2 is present in meconium and inhibits the activity of pulmonary surfactant: an in vitro study.
    Schrama AJ; de Beaufort AJ; Sukul YR; Jansen SM; Poorthuis BJ; Berger HM
    Acta Paediatr; 2001 Apr; 90(4):412-6. PubMed ID: 11332933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.
    Taeusch HW; Bernardino de la Serna J; Perez-Gil J; Alonso C; Zasadzinski JA
    Biophys J; 2005 Sep; 89(3):1769-79. PubMed ID: 15923228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants.
    Findlay RD; Taeusch HW; David-Cu R; Walther FJ
    Pediatr Res; 1995 Jan; 37(1):26-30. PubMed ID: 7700730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets.
    Balaraman V; Meister J; Ku TL; Sood SL; Tam E; Killeen J; Uyehara CF; Egan E; Easa D
    Am J Respir Crit Care Med; 1998 Jul; 158(1):12-7. PubMed ID: 9655700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct interactions between nitrous oxide and exogenous pulmonary surfactant in vitro.
    Sosnowski TR; Gradoń L; Marraro GA
    Exp Lung Res; 2004 Jun; 30(4):311-8. PubMed ID: 15204836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scoring of surface parameters of physiological relevance to surfactant therapy in respiratory distress syndrome.
    Banerjee R; Bellare JR
    J Appl Physiol (1985); 2001 Apr; 90(4):1447-54. PubMed ID: 11247946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of different surfactant preparations on bacterial growth in vitro.
    Neumeister B; Woerndle S; Bartmann P
    Biol Neonate; 1996; 70(2):128-34. PubMed ID: 8864432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of three surfactant preparations on in vitro lymphocyte functions.
    Woerndle S; Bartmann P
    J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.
    Cummings JJ; Holm BA; Hudak ML; Hudak BB; Ferguson WH; Egan EA
    Am Rev Respir Dis; 1992 May; 145(5):999-1004. PubMed ID: 1586078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
    Galan HL; Kuehl TJ
    Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of inhaled surfactant on pulmonary deposition and clearance of technetium-99m-DTPA radioaerosol.
    Suga K; Mitra A; Domingues C; Alderson PO
    J Nucl Med; 1998 Mar; 39(3):543-7. PubMed ID: 9529308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of pH on surface properties of lung surfactants.
    Amirkhanian JD; Merritt TA
    Lung; 1995; 173(4):243-54. PubMed ID: 7564483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Poly(ethylene glycol) (PEG) enhances dynamic surface activity of a bovine lipid extract surfactant (BLES).
    Lu JJ; Yu LM; Cheung WW; Goldthorpe IA; Zuo YY; Policova Z; Cox PN; Neumann AW
    Colloids Surf B Biointerfaces; 2005 Mar; 41(2-3):145-51. PubMed ID: 15737540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alveolar metabolism of natural vs. synthetic surfactants in preterm newborn rabbits.
    Allen V; Oulton M; Stinson D; MacDonald J; Allen A
    J Appl Physiol (1985); 2001 Jan; 90(1):198-204. PubMed ID: 11133911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol.
    Gunasekara L; Schürch S; Schoel WM; Nag K; Leonenko Z; Haufs M; Amrein M
    Biochim Biophys Acta; 2005 Oct; 1737(1):27-35. PubMed ID: 16216549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo.
    Raczka E; Kukowska-Latallo JF; Rymaszewski M; Chen C; Baker JR
    Gene Ther; 1998 Oct; 5(10):1333-9. PubMed ID: 9930338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.